Overview


The Organ Preservation Market encompasses products and technologies that maintain the viability of donor organs outside the body before transplantation. It is expanding rapidly due to more organ transplant procedures, rising organ failure rates, advancements in preservation methods, and supportive healthcare initiatives globally.

According to FutureWise analysis, the Organ Preservation market in Europe in 2026 is US$248.45 million and is expected to reach US$526.13 million by 2036, at a CAGR of 7.79%. The Organ Preservation market is experiencing significant growth, driven by the rising incidence of organ failure and increasing demand for organ transplantation. Key advancements in preservation techniques, including hypothermic and normothermic perfusion, are also contributing to this expansion.

Growth Drivers:

  • Rising Demand for Organ Transplants – The global need for organ transplants increases the demand for effective preservation solutions.
  • Advancements in Preservation Technologies – Innovations such as hypothermic and normothermic machine perfusion improve organ viability.
  • Increasing Chronic Disease Prevalence – More cases of organ failure heighten the need for preserved donor organs.
  • Supportive Healthcare Policies – Government initiatives and campaigns promote organ donation and preservation.

Key Trends:

  • Advanced machine perfusion improves organ viability.
  • AI and IoT integration enables smart monitoring.
  • Personalized preservation solutions for specific organs.
  • Cross-border organ sharing expands access.
  • Research on extended storage prolongs preservation times.

Market Segmentation and Key Players:

The Organ Preservation Market is segmented by solution type (e.g., UW solution, Custodial HTK, Perfadex), technique (static cold storage, hypothermic, and normothermic machine perfusion), organ type (kidneys, liver, lung, heart, other organs), and geography (North America, Europe, Asia Pacific, Latin America, Middle East & Africa). This segmentation provides insights into tailored products and services for various preservation needs and clinical environments. Comprehensive segmentation details are provided in the Segmentation section below.

Major companies operating in the Organ Preservation Market include Paragonix Technologies, XVIVO Perfusion AB, and Dr. Franz Köhler Chemie GmbH, among others, that drive innovation and supply across segments.

Research Methodology:

FutureWise Research's methodology for the Organ Preservation Market involves primary research through expert interviews and secondary research using reports and databases. Market sizing and forecasts are developed through top-down and bottom-up approaches, analyzing segments by solution type, technique, organ type, and geography. Data triangulation is applied to validate trends, growth drivers, and the competitive landscape for comprehensive insights.

  • Bristol-myers Squibb
  • Xvivo Perfusion AB
  • Paragonix Technologies
  • Franz Kohler Chemie Gmbh
  • Biolife Solutions Inc.
  • Claris Lifesciences Limited
  • Lifeline Scientific
  • Tolerotech Inc.
  • 21st Century Medicine
  • Cryolife Inc.

Recent developments by key players in the Organ Preservation Market:

Paragonix Technologies

  • Acquired by Getinge (Aug 2024): Paragonix agreed to be acquired by Getinge, expanding Getinge’s global reach in solid organ transplant technologies.
  • Launched a nationwide organ courier service alongside NORA in August 2024, enabling organs to be transported via commercial flights, reducing costs and emissions
  • As of March 2025, their devices had been used in over 10,000 transplant cases across more than 150 centers globally.

Xvivo Perfusion AB

  • Strategic partnership: In January 2024, XVIVO partnered with Getinge to integrate their lung perfusion systems with advanced life-support and monitoring platforms, co-developing AI monitoring for perfusion in Europe and North America.
  • Milestone clinical use: The UK’s first double-lung transplant using XVIVO’s XPS ex-vivo perfusion system was performed at Royal Papworth Hospital in December 2024, reviving and prolonging lung viability before transplant

21st Century Medicine

  • Known for pioneering aldehyde-stabilized cryopreservation techniques, including the successful vitrification of rabbit brains with cell-level preservation. Not directly recent developments, but foundational in long-term organ (and tissue) storage efforts.

The LIVERguard™ donor liver preservation system was introduced in October 2021 by Paragonix Technologies, the industry's top supplier of systems for preserving and transporting donor organs, for use in both clinical and commercial settings.

The major factor propelling the growth of the organ preservation market in the aforementioned forecast period is the rising incidence of organ failures in European countries, amid rapid geriatric population growth, along with various regional authorities providing favourable regulations across Europe. Additionally, factors such as organizing initiatives and developing awareness campaigns to increase the number of organ donors and transplant surgeries also accelerate the market's overall growth. According to estimates, the overall market growth is expected to accelerate during the projected period due to the rising prevalence of multi-organ failure and significant advancements in the nation's healthcare system. The market's growth is hampered by the high costs connected with organ transplantation, which limits the procedure being opted further resulting in a narrower consumer base.

By Solution

  • University of Wisconsin (UW)
  • Custodial HTK
  • Perfadex
  • Others (Celsior & Euro-Collins)

By Technique

  • Static Cold Storage
  • Hypothermic Machine Perfusion
  • Normothermic Machine Perfusion

By Organ Type

  • Kidneys
  • Liver
  • Lung
  • Heart
  • Others (Intestine & Pancreas)

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

This market research report also emphasizes factors affecting the growth rate in the various countries listed above. A comprehensive analysis of countries will also be provided in the final version of this market report, which is based on the conclusion of primary interviews and secondary data points gathered during the process.

Here’s a regional view of where the most progress is happening

North America
Position:
North America is currently at the forefront of market size, technological innovation, and clinical adoption of organ preservation solutions.

Key Drivers:

  • There is a high prevalence of organ transplantation procedures supported by a strong infrastructure for organ donation.
  • The presence of major companies like Paragonix Technologies, OrganOx, and XVIVO Perfusion is driving innovation in the industry.
  • Supportive regulatory frameworks and substantial investments in healthcare research and development (R&D) are essential.

The market is fueled by factors including expanding government, advanced goods and technology, and an increase in chronic ailments in the region. Germany is an appealing market because of its steady expansion and advanced approach to the healthcare industry. Federal Statistical Office estimates that Germany spent 460.03 billion US dollars on healthcare in 2019. Globally, there is still a great need for highly creative technology, as well as for therapeutic, diagnostic and minimally invasive equipment. The organ donation system has benefited from several government initiatives that have increased funds, supported laws, and built out infrastructure in this region.


  • Tier 1 players- established companies in the market with major market share
  • Tier 2 players
  • New Entrants
  • Emerging players which are growing rapidly

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data points affecting market growth

  • To provide with an exhaustive analysis on the Organ Preservation Market By Solution, By Technique, By Organ Type and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Organ Preservation Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Organ Preservation Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Organ Preservation Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Organ Preservation Market, By Solution Historical Analysis and Forecast 2026-2036 (USD Million)
    •   1. University of Wisconsin (UW)
        2. Custodial HTK
        3. Perfadex
        4. Others (Celsior & Euro-Collins)

  • 8.   Organ Preservation Market, By Technique Historical Analysis and Forecast 2026-2036 (USD Million)
    •   1. Static Cold Storage
        2. Hypothermic Machine Perfusion
        3. Normothermic Machine Perfusion

  • 9.   Organ Preservation Market, By Organ Type Historical Analysis and Forecast 2026-2036 (USD Million)
    •   1. Kidneys
        2. Liver
        3. Lung
        4. Heart
        5. Others (Intestine & Pancreas)

  • 10.   North America Organ Preservation Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2026-2036

  • 11.   Latin America Organ Preservation Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2026-2036

  • 12.   Europe Organ Preservation Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2026-2036

  • 13.   Asia Pacific Organ Preservation Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2026-2036

  • 14.   Middle East and Africa Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2026-2036

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Bristol-myers Squibb
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Xvivo Perfusion AB
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Paragonix Technologies
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Franz Kohler Chemie Gmbh.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Biolife Solutions Inc.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Claris Lifesciences Limited
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Lifeline Scientific
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Tolerotech Inc.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. 21st Century Medicine
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10.Cryolife Inc.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client

FAQ


The Organ Preservation Market encompasses technologies, devices, and solutions aimed at maintaining the viability of donor organs outside the body prior to transplantation. This market includes cold storage solutions, machine perfusion systems, and preservation media for various organs such as kidneys, livers, lungs, and hearts.

  • The number of organ transplant procedures is increasing globally.
  • There is an increasing occurrence of organ failure and chronic diseases.
  • Recent advancements in machine perfusion and preservation techniques, including hypothermic and normothermic methods.
  • There is an increasing emphasis on enhancing organ viability in order to minimize complications after transplantation.
  • Extended viability of donor organs.
  • Reduced transplant failure rates.
  • Better patient outcomes and wider access to organs.
  • Reduced wastage of precious donor organs.

Related Market

Cell and Tissue Preservation Market

Read More

Biopreservation Market

Read More

Cell Cryopreservation Market

Read More
Partner

Our Clients